← Leaderboards
Rolf Muller
Biofluidica, Inc
$4,070,997
Attributed
$4,070,997
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2017–20$2M$1.5M$1M$500K$0
'17
'18
'19
'20
Funding mix
By agency
NIH$4,070,997 · 5
By mechanism
R44$3,253,766 · 2
R43$817,231 · 3
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Microfluidics”
- Andrew Quong · Fluidigm Corporation$8,580,056
- Rebecca R Pompano · University Of Virginia$7,895,481
- Robert Nicol · Broad Institute, Inc.$7,498,771
- Jennifer M Munson · Virginia Polytechnic Inst And St Univ$7,011,606
- Natura Myeku · Columbia University Health Sciences$6,641,462
- Megan N McClean · University Of Wisconsin-Madison$5,645,011
Research focus
MicrofluidicsMicrofluidic MicrochipsRecoveryDiagnosticBaseLiquid SubstanceCellsDevicesReproducibilityPrecision MedicineMonitorBloodSamplingBlood SpecimenSecureNeoplastic CellProceduresRoboticsMinimally InvasiveAffinityCancer DiagnosisAntibodiesClinical ResearchImmobilization
Grant awards (8)
Increased sensitivity of minimal residual disease monitoring using peripheral blood in pediatric patients with acute lymphoblastic leukemia$556,708
R44 · FY2020 · CA · contact PI
Increased sensitivity of minimal residual disease monitoring using peripheral blood in pediatric patients with acute lymphoblastic leukemia$837,994
R44 · FY2019 · CA · contact PI
A microfluidic platform for the high-throughput isolation circulating fetal trophoblasts for non-invasive prenatal testing$291,545
R43 · FY2019 · HD · contact PI
Rapid detection of minimal residual disease in acute myeloid leukemia from peripheral blood$712,071
R44 · FY2018 · CA · contact PI
Increased sensitivity of minimal residual disease monitoring using peripheral blood in pediatric patients with acute lymphoblastic leukemia$348,768
R44 · FY2018 · CA · contact PI
Parallel and high throughput isolation of cfDNA to target detection of rare, highly conserved nucleotide polymorphisms$286,548
R43 · FY2018 · CA · contact PI
Parallel and high throughput isolation of cancer cell derived extracellular vesicles$239,138
R43 · FY2018 · CA · contact PI
Rapid detection of minimal residual disease in acute myeloid leukemia from peripheral blood$798,225
R44 · FY2017 · CA · contact PI